Autoimmune Polyglandular Syndrome Type 1
An Illustrative Overview
DOI:
https://doi.org/10.48112/bcs.v2i2.452Abstract
Abstract Views: 501
One of the rarest autoimmune diseases is the autoimmune polyglandular syndrome type 1 which is caused by defects in the AIRE gene leading to affection of several endocrine glands. Two out of three criteria are needed for diagnosis including hypoparathyroidism, adrenal insufficiency along with other non-endocrinal symptoms such as mucocutaneous candidiasis. Management of the condition is multidisciplinary with regular long-life follow-ups. Generally, there is a paucity of illustrative articles in literature about the pathogenesis and the main signs and symptoms of autoimmune polyglandular syndrome type 1 in a simplified manner which lead to the need for such articles. This article attempts to fill that void as an illustrative overview for the purpose of education and awareness about this condition because the early the treating physician can diagnose and accordingly treat the patient, the better the prognosis of the disease becomes with less morbidity and mortality rates.
Keywords:
APS-1, PGA-Type I, AIRE gene mutation, hypoparathyroidism, chronic mucocutaneous candidiasisReferences
Ahonen, P., Myllärniemi, S., Sipilä, I., and Perheentupa, J. (1990). Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. The New England journal of medicine, 322(26), 1829–1836. https://doi.org/10.1056/NEJM199006283222601
Alimohammadi, M., Björklund, P., Hallgren, Å., Pöntynen, N., Szinnai, G., Shikama, N., ... & Kämpe, O. (2008). Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen. New England Journal of Medicine, 358(10), 1018-1028. https://doi.org/10.1056/NEJMoa0706487
Alimohammadi, M., Dubois, N., Sköldberg, F., Hallgren, Å., Tardivel, I., Hedstrand, H., ... & Carel, J. C. (2009). Pulmonary autoimmunity as a feature of autoimmune polyendocrine syndrome type 1 and identification of KCNRG as a bronchial autoantigen. Proceedings of the national academy of Sciences, 106(11), 4396-4401. https://doi.org/10.1073/pnas.0809986106
Anderson, M. S., & Su, M. A. (2016). AIRE expands: new roles in immune tolerance and beyond. Nature reviews. Immunology, 16(4), 247–258. https://doi.org/10.1038/nri.2016.9
Betterle, C., Greggio, N. A., and Volpato, M. (1998). Clinical review 93: Autoimmune polyglandular syndrome type 1. The Journal of clinical endocrinology and metabolism, 83(4), 1049–1055. https://doi.org/10.1210/jcem.83.4.4682
Bjørklund, G., Pivin, M., Hangan, T., Yurkovskaya, O., & Pivina, L. (2022). Autoimmune polyendocrine syndrome type 1: Clinical manifestations, pathogenetic features, and management approach. Autoimmunity reviews, 21(8), 103135. https://doi.org/10.1016/j.autrev.2022.103135
Brun J. M. (1982). Juvenile autoimmune polyendocrinopathy. Hormone research, 16(5), 308–316. https://doi.org/10.1159/000179519
Bruserud, Ø., Oftedal, B. E., Landegren, N., Erichsen, M. M., Bratland, E., Lima, K., ... & Husebye, E. S. (2016). A longitudinal follow-up of autoimmune polyendocrine syndrome type 1. The Journal of Clinical Endocrinology & Metabolism, 101(8), 2975-2983. https://doi.org/10.1210/jc.2016-1821
Chen, J., Lu, T., Liu, C., Zhao, Y., Huang, A., Hu, X., Li, M., Xiang, R., Feng, M., and Lu, H. (2021). Autoimmune polyglandular syndrome type 1 with diabetes insipidus: a case report. BMC endocrine disorders, 21(1), 154. https://doi.org/10.1186/s12902-021-00822-6
Garelli, S., Dalla Costa, M., Sabbadin, C., Barollo, S., Rubin, B., Scarpa, R., ... & Betterle, C. (2021). Autoimmune polyendocrine syndrome type 1: an Italian survey on 158 patients. Journal of endocrinological investigation, 44(11), 2493-2510. https://doi.org/10.1007/s40618-021-01585-6
Husebye, E. S., Anderson, M. S., & Kämpe, O. (2018). Autoimmune Polyendocrine Syndromes. The New England journal of medicine, 378(12), 1132–1141. https://doi.org/10.1056/NEJMra1713301
Husebye, E. S., Perheentupa, J., Rautemaa, R., and Kämpe, O. (2009). Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I. Journal of internal medicine, 265(5), 514–529. https://doi.org/10.1111/j.1365-2796.2009.02090.x
Jacobson, J. D., Broussard, J. R., Marsh, C., and Newell, B. (2021). Attenuation of Autoimmune Phenomena in a Patient with Autoimmune Polyglandular Syndrome Type 1. Case reports in endocrinology, 2021, 6009141. https://doi.org/10.1155/2021/6009141
Kisand, K., & Peterson, P. (2015). Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy. Journal of clinical immunology, 35(5), 463–478. https://doi.org/10.1007/s10875-015-0176-y
Landegren, N., Sharon, D., Shum, A. K., Khan, I. S., Fasano, K. J., Hallgren, Å., ... & Kämpe, O. (2015). Transglutaminase 4 as a prostate autoantigen in male subfertility. Science translational medicine, 7(292), 292ra101-292ra101. https://doi.org/10.1126/scitranslmed.aaa9186
Moffett, J. M., & Suliburk, J. (2011). Parathyroid autotransplantation. Endocrine practice, 17, 83-89. https://doi.org/10.4158/EP10377.RA
Neufeld, M., Maclaren, N. K., and Blizzard, R. M. (1981). Two types of autoimmune Addison's disease associated with different polyglandular autoimmune (PGA) syndromes. Medicine, 60(5), 355–362. https://doi.org/10.1097/00005792-198109000-00003
Nwosu, I., Oladiran, O., Ogbonna-Nwosu, C., & Anyata, A. (2019). Autoimmune polyglandular syndrome type 1: a case report and brief review. Journal of community hospital internal medicine perspectives, 9(3), 252–254. https://doi.org/10.1080/20009666.2019.1616523
Orlova, E. M., Sozaeva, L. S., Kareva, M. A., Oftedal, B. E., Wolff, A. S., Breivik, L., ... & Husebye, E. S. (2017). Expanding the phenotypic and genotypic landscape of autoimmune polyendocrine syndrome type 1. The Journal of Clinical Endocrinology & Metabolism, 102(9), 3546-3556. https://doi.org/10.1210/jc.2017-00139
Parent, A. V., Russ, H. A., Khan, I. S., LaFlam, T. N., Metzger, T. C., Anderson, M. S., & Hebrok, M. (2013). Generation of functional thymic epithelium from human embryonic stem cells that supports host T cell development. Cell stem cell, 13(2), 219–229. https://doi.org/10.1016/j.stem.2013.04.004
Proust-Lemoine, E., & Wémeau, J. L. (2008). Syndrome Apeced ou polyendocrinopathie auto-immune de type 1. La Presse Médicale, 37(7-8), 1158-1171. https://doi.org/10.1016/j.lpm.2007.11.015
Shum, A. K., Alimohammadi, M., Tan, C. L., Cheng, M. H., Metzger, T. C., Law, C. S., ... & Anderson, M. S. (2013). BPIFB1 is a lung-specific autoantigen associated with interstitial lung disease. Science translational medicine, 5(206), 206ra139-206ra139. https://doi.org/10.1126/scitranslmed.3006998
Wang, Y. B., Wang, O., Nie, M., Jiang, Y., Li, M., Xia, W. B., & Xing, X. P. (2021). Characterization of the clinical and genetic spectrum of autoimmune polyendocrine syndrome type 1 in Chinese case series. Orphanet journal of rare diseases, 16(1), 296. https://doi.org/10.1186/s13023-021-01933-y
Yanase, T., Tajima, T., Katabami, T., Iwasaki, Y., Tanahashi, Y., Sugawara, A., ... & Kasayama, S. (2016). Diagnosis and treatment of adrenal insufficiency including adrenal crisis: a Japan Endocrine Society clinical practice guideline [Opinion]. Endocrine journal, 63(9), 765-784. https://doi.org/10.1507/endocrj.EJ16-0242
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Biomedicine and Chemical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
